Alpha Tau Medical Ltd. (DRTSW)

Market Cap	187.92M
Revenue (ttm)	n/a
Net Income (ttm)	-31.75M
Shares Out	70.38M
EPS (ttm)	-0.45
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	22,351
Open	0.2100
Previous Close	0.2188
Day's Range	0.2100 - 0.2188
52-Week Range	0.2100 - 0.2188
Beta	0.93
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 7, 2025

About DRTSW

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical or pending clinical studies for brain and other cancers. The company is headquartered in Jerusalem, Israel.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2015
• Employees: 125
• Stock Exchange: NASDAQ
• Ticker Symbol: DRTSW
• Website: https://www.alphatau.com